临床儿科杂志 ›› 2020, Vol. 38 ›› Issue (5): 367-.doi: 10.3969/j.issn.1000-3606.2020.05.013

• 综合报道 • 上一篇    下一篇

抗NMDAR 脑炎患儿痫性发作临床特征及预后

徐玄玄, 靳培娜, 马威, 王怀立   

  1. 郑州大学第一附属医院儿童重症监护室(河南郑州 450052)
  • 出版日期:2020-05-15 发布日期:2020-06-02
  • 通讯作者: 王怀立 电子信箱:whiek6527@126.com

Clinical characteristics of children with anti-NMDAR encephalitis and its impact on prognosis

 XU Xuanxuan, JIN Peina, MA Wei, WANG Huaili   

  1. The First Affiliated Hospital of Zhengzhou University, PICU, Zhengzhou 450052, Henan, China
  • Online:2020-05-15 Published:2020-06-02

摘要:  目的 分析儿童抗NMDAR脑炎痫性发作特点,探讨痫性发作对抗NMDAR脑炎的影响。方法 回顾分析 2014年4月至2019年1月收治的42例脑脊液抗NMDAR抗体阳性脑炎患儿的临床资料,并按急性期是否有痫性发作分为 两组,比较两组的临床资料及改良Rankin量表(mRS)评分,分析急性期痫性发作对抗NMDAR脑炎的影响;按随访期间 是否有痫性发作分组,比较两组mRS评分,分析恢复期痫性发作对患儿长期预后的影响。结果 42例抗NMDAR脑炎患儿, 男20例、女22例,发病年龄1~14岁。急性期有痫性发作29例(69%),其中全面性发作17例,发作频率>3次14例,癫痫 持续状态15例;无痫性发作13例(31%),随访期间出现失神发作1例。按急性期是否有痫性发作分组,两组间脑脊液有 核细胞数以及有核细胞异常比例差异均有统计学意义(P<0.05)。 按随访期间是否有痫性发作分组,两组间mRS评分分布 差异有统计学意义(P<0.05)。结论 抗NMDAR脑炎患儿急性期是否伴有痫性发作对患儿的脑电图、头颅MRI、抗体滴度、 恢复期是否再次出现痫性发作及长期预后均无影响,同时恢复期仍有痫性发作的患儿长期预后较差。

关键词: 痫性发作; 抗NMDAR脑炎; 抗体滴度; 预后

Abstract: Objective To analyze the characteristics of anti-NMDAR (N-methyl-D-aspartate receptor) encephalitis in children and to explore the effect of seizures against NMDAR encephalitis. Methods Clinical data of 42 children with positive cerebrospinal fluid anti-NMDAR antibodies from April 2014 to January 2019 were divided into two groups according to whether there is an epileptic seizure in the acute phase, and analyzed clinically. Clinical data and the modified ranking scores (mRS) scores of the two groups were compared and effects of seizures against NMDAR encephalitis were analyzed. According to whether there were seizures during follow-up, the mRS scores of the two groups were compared, and analysis of the effect of seizures during recovery on the long-term prognosis of children were performed. Results Of the 42 children with anti-NMDAR encephalitis, 29 (69%) had epileptic seizures, including 17 (58.6%) with general seizures, 14 (48.3%) with seizures greater than 3 times, and status epilepticus in 15 patients (51.7%). Of the children without epileptic seizures, one patient (7.7%) had a seizure during the follow-up period. The number of nucleated cells in the cerebrospinal fluid between the two groups according to the presence of epilepsy in the acute phase were compared, there is significant difference (P<0.05). According to whether there were seizures during follow-up, the mRS scores of the two groups were compared, and the difference was significant (P<0.05). Conclusion  Whether children with anti-NMDAR encephalitis are accompanied by seizures in the acute phase, it has no effect on the children's EEG, skull MRI, antibody titer, whether seizures recur in the recovery period and long-term prognosis. The long-term prognosis of children with seizures during the recovery period is poor.

Key words:  seizures; anti-NMDAR encephalitis; antibody titer; prognosis